Bisphosphonates in corticosteroid-induced osteoporosis

Clinical Reviews in Bone and Mineral Metabolism

Volumn 5, Issue 3, 2007, Pages 153-158

  Sambrook, Philip N ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Fracture; Glucocorticoids; Osteoporosis

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CALCIUM CARBONATE; CORTICOSTEROID; CYCLOSPORIN; ERGOCALCIFEROL; ETIDRONIC ACID; IBANDRONIC ACID; PAMIDRONIC ACID; PARATHYROID HORMONE; PLACEBO; PREDNISOLONE; PREDNISONE; RISEDRONIC ACID; VITAMIN D;

ABSENCE OF SIDE EFFECTS; BILIARY CIRRHOSIS; BONE DENSITY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CORTICOSTEROID INDUCED OSTEOPOROSIS; HUMAN; LOW DRUG DOSE; MONOTHERAPY; OSTEOLYSIS; POSTMENOPAUSE; REVIEW; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS;

EID: 49349095996     PISSN: 15348644     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12018-007-9000-4     Document Type: Review

References (23)

1. RS Weinstein JR Chen C Powers SA Stewart RD Landes T Bellido RL Jilka AM Parfitt SC. Manolagas 2002 Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids J Clin Invest 109 1041 8
2. IR Reid AR King CJ Alexander HK. Ibbertson 1988 Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidine)-1, 1-bisphosphonate (APD) Lancet i 143 6
3. Y Boutsen J Jamart W Esselinckx M Stoffel JP. Devogelaer 1997 Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: a randomized trial Calcif Tiss Int 61 266 71
4. Y Boutsen J Jamart W Esselinckx JP. Devogelaer 2001 Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone J Bone Miner Res 16 104 12
5. H Mulder J. Struys 1994 Intermittent cyclical etidronate in the prevention of corticosteroid induced bone loss Br J Rheumatol 33 348 50
6. T Diamond L McGuigan S Barbagallo C. Bryant 1995 Cyclical etidronate plus ergocalciferol prevents corticosteroid-induced bone loss in postmenopausal women Am J Med 98 459 63
7. JD Adachi WG Bensen J Brown D Hanley A Hodsman R Josse DL Kendler B Lentle W Olszynski LG Ste-Marie A Tenenhouse AA. Chines 1997 Intermittent etidronate therapy to prevent glucocorticoid-induced osteoporosis New Eng J Med 337 382 7
8. F Wolfhagen H Van Buuren J Den Ouden W Hop J Van Leeuwen S Schalm H. Pols 1997 Cyclical etidonate in the prevention of bone loss in corticosteroid- treated primary biliary cirrhosis J Hepatol 26 325 30
9. P Geusens J Dequeker J Vanhoof R Stalmans S Boonen J Joly J Nijs J. Raus 1998 Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment. A double blind, randomised placebo controlled study Ann Rheum Dis 57 724 7
10. C Roux P Oriente R Laan RA Hughes J Ittner JM Kaufman O Di Munno JM Pouillies S Horlait B. Cortet 1998 A randomsed trial of effect of cyclical etidronate in the prevention of corticosteroid induced bone loss J Clin Endocr Metab 83 1128 33
11. P Pitt B Bloom P Todd S Pack G Hughes CA. Moniz 1998 A double blind placebo controlled study to determine the effects of intermittent cyclical etidonate on bone mineral density in patients on long term corticosteroid treatment Thorax 53 351 6
12. EA Jenkins KE Walker-Bone A Wood FC McCare C Cooper MID. Cawley 1999 The prevention of corticosteroid induced osteoporosis with intermittent cyclical etidonate Scand J Rheumatol 28 152 6
13. NK Henderson JA Eisman A Keogh P MacDonald A Glanville P Spratt PN. Sambrook 2001 Protective effect of short term calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation J Bone Miner Res 16 565 71
14. IA Campbell JG Douglas RM Francis RJ Prescott DM. Reid 2004 Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids Thorax 59 761 8
15. K Saag R Emkey TJ Schnitzler JP Brown F Hawkins S Goemaere G Thamsborg UA Liberman PD Delmas MP Malice M Czachur AG. Daifotis 1998 Alendronate for the prevention and treatment of glucocorticoid induced osteoporosis New Eng J Med 339 292 9
16. JD Adachi KG Saag PD Delmas UA Liberman RD Emkey E Seeman NE Lane JM Kaufman PE Poubelle F Hawkins R Correa-Rotter CJ Menkes JA Rodriguez-Portales TJ Schnitzer JA Block J Wing HH McIlwain R Westhovens J Brown JA Melo-Gomes BL Gruber MJ Yanover MO Leite KG Siminoski MC Nevitt JT Sharp MP Malice T Dumortier M Czachur W Carofano A. Daifotis 2001 Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial Arthritis Rheum 44 201 11
17. PM Chavassieux ME Arlot JP Roux N Portero A Daifotis AJ Yates NA Hamdy MP Malice D Freedholm PJ. Meunier 2000 Effects of alendronate on bone quality and remodelling in glucocorticoid-induced osteoporosis: a histomorphometric analysis of transiliac biopsies J Bone Miner Res 15 1754 62
18. S Gonnelli P Rottoli C Cepollaro C Pondrelli V Capiello M Vagliasindi C. Gennari 1997 Prevention of corticosteroid-induced osteoporosis with alendronate in sarcoid patients Calcif Tiss Int 61 382 5
19. PN Sambrook M Kotowicz P Nash CB Styles V Naganathan KN Henderson-Briffa JA Eisman GC. Nicholson 2003 Prevention and treatment of glucocorticoid induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium and alendronate plus calcium J Bone Miner Res 18 919 24
20. S Cohen RM Levy M Keller E Boling RD Emkey M Greenwald TM Zizic S Wallach KL Sewell BP Lukert DW Axelrod AA. Chines 1999 Residronate therapy prevents glucocorticoid-induced bone loss Arthritis Rheum 42 2309 18
21. DM Reid RA Hughes RFJM Laan NA Sacco-Gibson DH Wenderoth S Adami R Eusebio JP. Devogelaer 2000 Efficacy and safety of daily risedronate in the treatment of glucocorticoid induced osteoporosis in men and women: a randomised trial J Bone Miner Res 15 1006 13
22. S Wallach S Cohen DM Reid RA Hughes DJ Hosking RF Laan SM Doherty M Maricic C Rosen J Brown I Barton AA. Chines 2000 Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy Calcif Tiss Int 67 277 85
23. JD Ringe A Dorst H Faber K Ibach F. Sorenson 2003 Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study Osteoporosis Int 14 801 7